In clinical samples from the TCGA HNSCC cohort, no significant difference in CREBBP (Supplementary Fig. 7c) or EP300 (Supplementary Fig. 7d) gene expression was observed in mutant tumors. The gene discussed is EP300; the disease is head and neck squamous cell carcinoma.